Oaktree Capital Management Refinances $85MM Loan Facility with Oxford Biomedica
Oxford Biomedica, a gene and cell therapy group, refinanced the $85 million secured 12-month loan facility from funds managed by Oaktree Capital Management.
October 10, 2022
Aman Kumar | Oaktree Capital Management | Oxford BioMedica | Stuart Paynter
Ian Koplin